Indications for intravenous gammaglobulin therapy in inflammatory myopathies.
Open Access
- 1 November 1994
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 57 (Suppl) , 50-54
- https://doi.org/10.1136/jnnp.57.suppl.50
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- High-dose intravenous human immunoglobulin in polymyositis resistant to treatment.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Intravenous immunoglobulin for polymyositis and dermatomyositisThe Lancet, 1990
- CYCLOSPORIN IN JUVENILE DERMATOMYOSITISThe Lancet, 1989
- Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopeniaThe Journal of Pediatrics, 1986
- Gamma‐globulin Therapy in 6 Newly Diagnosed Diabetic ChildrenActa Paediatrica, 1985
- SUCCESSFUL RESPONSE TO INTRAVENOUS IMMUNOGLOBULIN IN AUTOIMMUNE HAEMOLYTIC ANAEMIABritish Journal of Haematology, 1985
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVISThe Lancet, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- POLYMYOSITIS: REMARKABLE RESPONSE TO TOTAL BODY IRRADIATIONThe Lancet, 1981
- Methotrexate therapy in polymyositis.Annals of the Rheumatic Diseases, 1973